Small Molecule Innovator CDMO 2024 Industry Size, Status, Analysis and Forecast 2030

Small Molecule Innovator CDMO Industry Overview

The global small molecule innovator CDMO market size was estimated at USD 48.6 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.21% from 2024 to 2030. Key drivers for this growth are increasing pharmaceutical R&D investment, growing demand for small molecules, and rising incidence of cancer & age-related disorders. Biological drugs are more expensive than small molecules. Hence, growing demand for cost-effective drugs is expected to further support market growth.

The COVID-19 pandemic significantly impacted on global economy in 2020 and caused an ongoing impact on various industries. However, the market for contract development and manufacturing organization (CDMO) witnessed a positive impact due to this pandemic. CDMOs played an important role in meeting the needs of pharmaceutical companies, biotech companies, and other end-users during this crisis. Overall, pandemic boosted market demand for small molecule innovator drugs. With the growing demand for outsourcing by pharma companies, heightened demand is observed in post-pandemic scenario.

Gather more insights about the market drivers, restrains and growth of the Small Molecule Innovator CDMO Market

Small Molecule Innovator CDMO Market Segmentation

Grand View Research has segmented the global small molecule innovator CDMO market based on product, stage type, customer type, therapeutic area, and region:

Small Molecule Innovator CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)

·        Small Molecule API

·        Small Molecule Drug Product

o   Oral solid dose

o   Semi-Solid Dose

o   Liquid Dose

o   Others

Small Molecule Innovator CDMO Stage Type Outlook (Revenue, USD Million, 2018 - 2030)

·        Preclinical

·        Clinical

o   Phase I

§  Small

§  Medium

§  Large

o   Phase II

§  Small

§  Medium

§  Large

o   Phase III

§  Small

§  Medium

§  Large

·        Commercial

Small Molecule Innovator CDMO Customer Type Outlook (Revenue, USD Million, 2018 - 2030)

§  Pharmaceutical

o   Small

o   Medium

o   Large

o   Biotechnology

Small Molecule Innovator CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

·        Cardiovascular disease

·        Oncology

·        Respiratory disorders

·        Neurology

·        Metabolic disorders

·        Infectious disease

·        Others

Small Molecule Innovator CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)

·        North America

o   U.S.

o   Canada

·        Europe

o   U.K.

o   Germany

o   France

o   Italy

o   Spain

o   Denmark

o   Sweden

o   Norway

·        Asia Pacific

o   India

o   Japan

o   China

o   Australia

o   South Korea

o   Thailand

·        Latin America

o   Brazil

o   Mexico

o   Argentina

·        Middle East & Africa

o   South Africa

o   Saudi Arabia

o   UAE

o   Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

·         The global intrauterine devices market size was estimated at USD 6.25 billion in 2023 and is projected to grow at a CAGR of 3.66% from 2024 to 2030.

·         The global dual chamber prefilled syringes market size was valued at USD 167.3 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.

Key Companies & Market Share Insights

Companies are undertaking various strategic initiatives to gain a competitive advantage. Key parameters affecting the competitive nature of the market include acquisition, geographic expansion, mergers, acquisitions, and product launches.

In September 2022, WuXi STA inaugurated a new sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its Wuxi city campus. The integrated drug product platform CRDMO provides a full range of services, including solid-state development, pre-formulation, and clinical to commercial drug product manufacturing.

In June 2022, Lonza inaugurated a new clinical phase development and manufacturing facility in its small molecules site in Bend, Oregon. It is dedicated to manufacturing bioavailability-enhancing spray-dried dispersion (SDD) finished dosage forms and drug product intermediates

List of Key Players of Small Molecule Innovator CDMO Market

·         Piramal Pharma Solutions

·         CordenPharma International

·         Wuxi AppTec

·         Cambrex Corporation

·         Recipharm AB

·         Pantheon (Thermo Fisher Scientific)

·         Lonza

·         Catalent Inc.

·         Siegfried Holding AG

·         Boehringer Ingelheim

·         Labcorp Drug Development

Order a free sample PDF of the Small Molecule Innovator CDMO Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Industry Outlook of Fuel Cell Market 2023 Trends to 2030

  Fuel Cell Industry Overview The global fuel cell market size was estimated at USD 7.35 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 27.1% from 2024 to 2030. Increasing demand for unconventional energy sources is one of the key factors driving the growth. Growing private-public partnerships and reduced environmental impact are expected to propel the demand. Governments across the globe are anticipated to supplement the developments by offering support in different forms, including funding R&D activities and funding suitable financing programs. Building a robust regulatory framework is vital as government enterprises need to provide an environment that is favorable for investment. Gather more insights about the market drivers, restrains and growth of the  Fuel Cell Market Most of the U.S. states, such as California and New York, have set mandates to limit the carbon emissions from commercial and industrial end users in the countr...
Read more

ENT Devices Market Segmentation, Application, Trends, Opportunity & Forecast 2024 To 2030

  ENT Devices Industry Overview The global ENT devices market size was estimated at USD 25.93 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.54% from 2024 to 2030. This growth can be attributed to several factors, such as high prevalence of ENT-related disorders, an increase in the usage of minimally invasive ENT procedures, and rising geriatric population. Technological advancements also play a crucial role in driving the market growth. The demand for advanced ENT devices, like robot-assisted endoscopes, is more in developed countries such as the U.S. while it is less in developing countries due to their high cost. The ENT devices market penetration is anticipated to grow significantly due to increasing healthcare spending by other governments and a rise in per capita income. Sales are expected to increase rapidly in developing economies due to high occurrences of ENT diseases such as hearing loss and sinusitis. Additionally, there is an i...
Read more

Smart Ticketing 2023 Industry Size, Demands, Growth and Top Key Players Analysis Report

  Smart Ticketing Industry Overview The global smart ticketing market size was valued at USD 10.14 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 15.5% from 2023 to 2030. The primary factor leading to the growth in adopting smart ticketing solutions is the increasing incorporation of emerging technologies. The introduction of innovative means for purchasing and paying for tickets, such as contactless payment systems, virtual tickets (E-tickets), and smart cards, enables smooth and efficient transit. In addition, the availability of multi-modal disbursement channels through online ticketing systems, smartphones, E-kiosks, and smart ticketing machines is supplementing effective crowd management and making smart ticketing systems preferable over traditional paper-based ticketing systems. Gather more insights about the market drivers, restrains and growth of the Smart Ticketing Market Moreover, changing customer preferences for digital channe...
Read more